PharmaDEXI
ActiveSummary
The computed 12-month bankruptcy probability of PharmaDEXI is 13.5% (high). For PharmaDEXI, at least two annual filings are missing. The 2023 annual accounts show negative equity (-€40,156) and a net result of -€14,540. The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Overview
Official details
Source: KBO- Status
- Active since 15-07-2021 Normal situation
- Registered office
- 13 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 3 November 2026.
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.320.278.404 1050 Elsene, since 15-07-2021
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- 13.5%
- Gross margin
- -€9,252
- ▲ 41.9%
- Loss
- €14,540
- ▼ 52.5%
- Equity
- -€40,156
- ▼ 56.8%
- Total assets
- €29,457
- ▼ 6.4%
- Negative equity on 31-12-2023
- 2024 accounts not filed, 460 days past the deadline
Signalsraises riskFigures for financial year 2023 (filed on 30-08-2024)No filing in 24 months (latest 30-08-2024)No main activity registeredTwo or more financial years not filed2023 accounts filed 30 days latelowers riskSize: total assets €29,457Show the evidence
Bankruptcy probability
About 1 in 7 comparable companies go bankrupt within 12 months (an estimate).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 22 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
Financials
Financials · financial year 2023, micro format
2024 annual accounts not yet filed, deadline passed on 31 July 2025 The financial year closed on 31 December 2024. The accounts are due at the latest 7 months after the close (Companies Code art. 3:10). 2 financial years without a filing since the last one filed. Source: NBB filings, as of 3 November 2026.
Annual accounts 2023 filed on 30-08-2024 PDF all 2 filings
Every figure per financial year
The operating result for 2023 is a loss of €14,459, smaller than the loss of €30,539 in 2022.
Turnover and EBIT margin are not published. The micro format does not require them.
Investments
| Item | 2022 | 2023 |
|---|---|---|
| Intangible fixed assets | €33,813 | - |
| Financial fixed assets | €900 | - |
| Depreciation and write-downs of the year | €14,559 | €2,817 |
Source: notes to the 2022 to 2023 annual accounts (statement of fixed assets)
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €14,559 | €2,817 | ▼ 80.6% |
| Other operating charges640/8 | €62 | €2,390 | ▲ 39× |
| Gross operating margin9900 | -€15,918 | -€9,252 | ▲ 41.9% |
| Operating profit (loss)9901 | -€30,539 | -€14,459 | ▲ 52.7% |
| Financial charges65/66B | €77 | €81 | ▲ 5.2% |
| Recurring financial charges65 | €77 | €81 | ▲ 5.2% |
| Profit (loss) for the period before taxes9903 | -€30,616 | -€14,540 | ▲ 52.5% |
| Profit (loss) for the period9904 | -€30,616 | -€14,540 | ▲ 52.5% |
| Profit (loss) for the period to be appropriated9905 | -€30,616 | -€14,540 | ▲ 52.5% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €31,477 | €29,457 | ▼ 6.4% |
| Fixed assets21/28 | €20,154 | €17,337 | ▼ 14.0% |
| Intangible fixed assets21 | €19,254 | €16,437 | ▼ 14.6% |
| Financial fixed assets28 | €900 | €900 | = |
| Current assets29/58 | €11,323 | €12,120 | ▲ 7.0% |
| Amounts receivable within one year40/41 | €11,323 | €10,472 | ▼ 7.5% |
| Trade receivables40 | €9,155 | €10,159 | ▲ 11.0% |
| Other amounts receivable41 | €2,168 | €313 | ▼ 85.6% |
| Cash at bank and in hand54/58 | - | €1,648 | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €31,477 | €29,457 | ▼ 6.4% |
| Equity10/15 | -€25,616 | -€40,156 | ▼ 56.8% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | -€30,616 | -€45,156 | ▼ 47.5% |
| Amounts payable17/49 | €57,093 | €69,612 | ▲ 21.9% |
| Amounts payable within one year42/48 | €57,093 | €69,612 | ▲ 21.9% |
| Financial debts43 | €4,510 | - | - |
| Credit institutions430/8 | €4,510 | - | - |
| Trade debts44 | €13,438 | €12,422 | ▼ 7.6% |
| Suppliers440/4 | €13,438 | €12,422 | ▼ 7.6% |
| Advances received on contracts in progress46 | €830 | - | - |
| Other amounts payable47/48 | €38,315 | €57,190 | ▲ 49.3% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | -€30,616 | -€14,540 | ▲ 52.5% |
| + Depreciation and write-downs630 | €14,559 | €2,817 | ▼ 80.6% |
| Operating cash flow (approximation) | -€16,057 | -€11,723 | ▲ 27.0% |
| Investment in fixed assets (approximation) | - | €0 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Board & ownership
Directors
Owners and capital
Shareholders
- Mohamed Bouria to Annes Bouria
- RABEMANANTSOA Andry all shares
Capital transactions
- 26-01-2023 Capital increase of €12,500 · to €52,500 · 100 new shares
Network & group
PharmaDEXI shares no director with another company.
Companies at the same address
12 other companies- Odi, Elom (sole trader) Establishment · since 2026 1025459551
- AU MENTAL Registered office · since 2025 1030330931
- Switzerland Cheese Marketing BNL Registered office · since 2015 0631782081
- Grande Teinturerie Royale Registered office · since 2014 0400527648
- Mofre Registered office · since 2014 0412873372
- Monif Registered office · since 2014 0413018575
- FLUPKE Establishment · since 2013 0536812945
- Newsville Registered office · since 2011 0841760555
- DECISIA Registered office · since 2008 0899729141
- ADMITIS Establishment · since 2007 0892662393
Connections & network
1 current directorThe network starts from the directors of PharmaDEXI. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
03-01
Gazette deed
Capital & shares · Resignations & appointmentsShare transfer4 points ▸
- General meeting, 29-09-2023
- Other provision, “actionnaire, démission comme actionnaire” (deed in French)
- Other provision, “actionnaire, nomination comme actionnaire” (deed in French)
- Share transfer, Mohamed Bouria → Annes Bouria
26-01
Gazette deed
Capital increase of €12,500 to €52,500Shareholding · Power of attorney · Bank account19 points ▸
- General meeting, 23-01-2023
- RABEMANANTSOA Andry holds all the shares
- Power of attorney, Michaelina de Radzitzky, mentioned 2 times in the deed
- Other provision, “apport en espèces 12500 avec émission 100 actions nouvelles, souscription-libération” (deed in French)
- Other provision, “expresse et irrévocable, justification du prix d'émission et conséquences sur droits patrimoniaux et sociaux” (deed in French)
- Capital contribution, €12,500
- Share issue, 100, “mêmes droits et avantages que actions existantes” (deed in French)
- Other provision, “renonciation aux conditions d'admission des nouveaux actionnaires, CSA et article 9 des statuts” (deed in French)
- Other provision, “à titre individuel et de manière expresse et irrévocable, renonciation au droit de préférence et délai d'exercice” (deed in French)
- Other provision, “intégralité des apports complémentaires en numéraire, souscription” (deed in French)
- Bank account, “CBC, BE92732067538323” (deed in French)
- Other provision, “pacte d'actionnaires annexé, annexent à la présente un pacte d'actionnaires” (deed in French)
- The act holds 7 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21447B0298/00W013 | Brussels | 1,244 m² | 1 · 389 m² | 19.6 m · 4 |